Absorption, distribution, metabolism, excretion, and pharmacokinetics of remibrutinib, an oral, highly selective Bruton tyrosine kinase inhibitor, in healthy participants at steady state

Drug Metabolism and Disposition · Elsevier

Аннотация

Publication date: November 2026 Source: Drug Metabolism and Disposition, Volume 54, Issue 11 Author(s): Alexander David James, Frederic Lozac’h, Melissa Hackling, Marie-Anne Lozac’h, Bharti Shah, Jeanne Hardy, Anton Drollmann, Ad Roffel, Gilbert Lefèvre

Читать у издателя →

Похожие статьи